Lugaro Cells, a distinct type of interneuron found in the human brain, particularly in the cerebellum, contribute to the intricate neural circuitry and play a role in regulating motor functions and coordination. Named after the Italian neuroscientist Gustavo Lugaro, who first described them in the early 20th century, these cells are characterized by their unique morphology and branching dendrites. Lugaro cells primarily inhibit the activity of neighboring neurons through the release of the neurotransmitter gamma-aminobutyric acid (GABA). While their precise role in cerebellar function is not fully understood, it is believed that Lugaro cells contribute to the fine-tuning of motor movements and coordination by modulating the activity of Purkinje cells, the principal output neurons of the cerebellum. Dysfunction of cerebellar circuits, including Lugaro cells, has been implicated in various movement disorders and ataxias. Studying the properties and connectivity of Lugaro cells provides valuable insights into the complexity of neural networks and their role in motor control. Advances in neuroscience techniques, such as electrophysiology and imaging, continue to enhance our understanding of Lugaro cells and their contribution to cerebellar function, with potential implications for therapeutic interventions in neurological disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy